Abstract
The antimyotonic effect of the antiarrhythmic drug tocainide was tested in 14 patients. With 1200 to 1600 mg/d all patients reported good improvement. This was substantiated by objective tests. Only four patients noticed minor side effects.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Anilides / adverse effects
-
Anilides / therapeutic use*
-
Anti-Arrhythmia Agents* / adverse effects
-
Female
-
Humans
-
Male
-
Middle Aged
-
Myotonia / drug therapy*
-
Tocainide
Substances
-
Anilides
-
Anti-Arrhythmia Agents
-
Tocainide